PFIX: Good Product But Risky Part Of Cycle

Montes-Bradley With hindsight, the trade of the cycle was to short long duration Treasuries on surging interest rates due to the fastest rate hike cycle in history. And certain products, like the Simplify Interest Rate Hedge ETF (NYSEARCA:PFIX), really thrived in terms of not just the timing of their launch, but performance, execution, and assets…

Read More

Upstart: Still Too Risky (NASDAQ:UPST)

JHVEPhoto Upstart Holdings (NASDAQ:UPST) wants to disrupt the lending market through its AI platform, but so far the monetization of its customer and partners’ base is not great, raising questions about the sustainability of its business model. Company Overview Upstart is a fintech company, combining technological capabilities applied to the financial sector, namely it offers…

Read More

PPG Industries: Hold, The North American Strategic Review Is Risky (NYSE:PPG)

Liudmila Chernetska/iStock via Getty Images Investment Thesis PPG Industries, Inc. (NYSE:PPG) shares have gained about 11% over the last year. Although this stock has an attractive dividend policy and its growth metrics are very appealing, my midterm outlook of this stock is skeptical following its strategic review of North American architectural coatings. From a technical…

Read More

Buyout Shops Take Risky Exit To Bypass Deal Crash

E_Y_E/iStock via Getty Images By Breakingviews Buyout firms have an even bigger problem than finding a place to park fleets of armored cars heaving with cash: what to do about their idling truckloads of portfolio companies. The two main avenues for returning money to increasingly itchy investors are largely blocked. To get around them, the…

Read More

3 Risky Office REITs (Dumpster Fire Alert)

John Webb/iStock via Getty Images This article was coproduced with Leo Nelissen. I don’t think anyone has ever used “dumpster diving” in a positive context. However, did you know some people make decent money dumpster diving? Last year, Business Insider published an article with the interesting title: “We met dumpster diving 14 years ago and…

Read More

DFCF ETF: Risky Bet In A ‘Higher For Longer’ Interest Rate Environment

William_Potter The Dimensional Core Fixed Income ETF (NYSEARCA:DFCF) is a great way to play the global investment-grade bond market. Benchmarked against the Bloomberg Agg, or Bloomberg U.S. Aggregate Bond Index, DFCF offers exposure to long-duration bonds and other fixed-income securities that, in the aggregate, are expected to maximize the total return for investors. While the…

Read More

Elbit Systems Stock Is Much Too Risky (NASDAQ:ESLT)

Christopher Furlong/Getty Images News Responsible investing being one of my twin areas of interest, I write mostly about companies that are champions of sustainability in their respective industries. Occasionally I cover ESG laggards and firms with intrinsically high ESG risks. Elbit Systems (NASDAQ:ESLT) is a plain example of the latter. The company has been dropped…

Read More

Crescent Capital BDC’s Dividend Is Getting More Risky (Downgrade) (NASDAQ:CCAP)

ADragan/iStock via Getty Images Crescent Capital BDC, Inc. (NASDAQ:CCAP) is a well-managed business development company, but headwinds to the BDC sector with respect to interest rates could hurt the company’s growth potential as it focused heavily on the creation of a floating-rate investment portfolio. The BDC’s merger with First Eagle Alternative Capital BDC accentuated this…

Read More

NuCana Stock: Potential Turnaround In 2024 But Risky (NASDAQ:NCNA)

vdvornyk/iStock via Getty Images Thesis overview NuCana (NASDAQ:NCNA) is a UK-based biotech developing nucleotide molecules for various oncology indications. Its platform, called ProTide, has major advantages over traditional nucleoside analogues currently used as part of chemotherapy regimens. NCNA’s lead candidate is NUC-3373 (ProTide 5-fluorouracil). NCNA aims to replace traditional 5-fluoroucil (5FU) which is still being…

Read More

Too Risky To Buy Now After The Parabolic Rise? (SP500)

MCCAIG/iStock via Getty Images The global macro playbook As a global macro investor/trader, my stock market strategy is fairly simple, I am long stock by default unless: The Fed is expected to increase interest rates aggressively. There is an imminent recession. There is a risk of an imminent systemic credit event. Accordingly, I was bearish…

Read More

DVYE: More Risky Than It Seems, Uncertain Dividend Trends

tum3123 Russia’s invasion of Ukraine resulted in cascading volatility across emerging markets and portfolio management strategies last year. Many Russia-domiciled companies were marked to zero in terms of equity value, hurting ETFs with significant exposure to said firms. One such fund was the iShares Emerging Markets Dividend ETF (NYSEARCA:DVYE). Morningstar noted, back in early 2022,…

Read More

Karyopharm Therapeutics: Promising Potential With 3 Ongoing Phase 3 Studies But Risky

wildpixel Thesis overview Karyopharm’s (NASDAQ:KPTI) lead candidate is selinexor, which has a novel mechanism of action. It acts as a selective inhibitor of nuclear export by binding to exporting 1 (XPO1). KPTI has been the leader in targeting this pathway and has successfully developed selinexor, with 3 approvals so far; in penta-refractory multiple myeloma, in…

Read More

Seres Therapeutics: Much Better Risk-Reward At Current Price, But Still Risky

Dr_Microbe Summary of prior coverage This is an update of my previous coverage of Seres Therapeutics (NASDAQ:MCRB). To sum up my prior coverage, VOWST (MCRB’s flagship and only approved product) represents the first commercial FDA-approved orally administered microbiome-based therapy in capsule form for prevention of recurrent C. difficile infection [CDI]. VOWST is approved for 1st…

Read More

AVK: Good Concept, But Risky (NYSE:AVK)

Dmytro Skrypnykov The Advent Convertible & Income Fund (NYSE:AVK) is a closed-end fund, or CEF, that income-focused investors can utilize to achieve their goals. This is immediately apparent in the fund’s whopping 14.12% yield, which puts most other income-focused funds to shame. This fund also has a few advantages over many other fixed-income funds. This…

Read More

WW International: Dying Core Business Overshadows Risky Pivot (NASDAQ:WW)

Prostock-Studio WW International (NASDAQ:WW) has struggled for years with its core Weight Watchers business, facing falling revenues and subscribers in a highly competitive market. While the company’s recent acquisition of Sequence Health looks like a bold strategic play to pivot into weight loss medications, this high-risk move is unlikely to turn around WW’s weak fundamentals….

Read More

Liquidity Services: Risky B2B Ecommerce Player, But Undervalued (NASDAQ:LQDT)

PeopleImages Liquidity Services, Inc. (NASDAQ:LQDT) reported impressive quarterly transaction growth and visitor growth in some of its B2B ecommerce subdivisions. A quick look at the platforms offered reveals data engineering and marketing campaigns that seemed to receive significant attention from well-known business conglomerates in different industries. I believe that more agreements with large B2C ecommerce…

Read More